Detalles de la búsqueda
1.
Alzheimer's disease-associated P460L variant of EphA1 dysregulates receptor activity and blood-brain barrier function.
Alzheimers Dement
; 20(3): 2016-2033, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184788
2.
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Blood
; 137(22): 3064-3078, 2021 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512408
3.
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers.
Haematologica
; 106(4): 958-967, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32381576
4.
Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL.
Br J Haematol
; 188(6): 872-880, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702049
5.
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
Blood
; 128(4): 563-73, 2016 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27252234
6.
Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia.
Blood
; 123(23): 3607-17, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24637360
7.
The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
Br J Haematol
; 161(1): 57-67, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23356405
8.
The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.
Haematologica
; 96(3): 393-9, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21134979
9.
Phosphoramidates of 2'-beta-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism.
Bioorg Med Chem
; 18(7): 2439-46, 2010 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20299228
10.
Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
Br J Haematol
; 141(4): 483-93, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18373709
11.
Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts.
Haematologica
; 93(5): 662-9, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18367484
12.
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine.
Oncotarget
; 5(2): 375-85, 2014 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24495868
13.
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73.
Oncotarget
; 5(17): 7691-704, 2014 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25277198
14.
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.
Oncotarget
; 3(5): 525-34, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22619113
15.
The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomib.
Mol Cancer Ther
; 9(6): 1574-82, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20515939
16.
FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.
Br J Haematol
; 139(1): 94-7, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17854312
Resultados
1 -
16
de 16
1
Próxima >
>>